Patents by Inventor Richard T. Mahon

Richard T. Mahon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Male continence device
    Patent number: 11911254
    Abstract: A surgically implanted occluding assembly comprises an implant body having a longitudinally split generally “C”-shaped cross-section tube circumscribing an anatomical lumen. In one embodiment, the surgically implanted occluding assembly is a male continence device selectively occluding a urethra. In some embodiments an occluding magnet is rigidly affixed with the implant body, and an external selective occlusion control assembly is used to selectively activate the surgically implanted occluding assembly. The external assembly has a magnet, and body supporting the magnet. The external selective occlusion control assembly is configured to be selectively placed and retained adjacent to the surgically implanted occluding assembly.
    Type: Grant
    Filed: January 24, 2023
    Date of Patent: February 27, 2024
    Inventors: Richard A. Helms, Ken L. Adam, Lewis A. Ratajczak, Joseph T. Mahon, Scott A. Olson
  • USE OF TIOTROPIUM BROMIDE TO PREVENT PULMONARY OXYGEN TOXICITY
    Publication number: 20190290623
    Abstract: A method for the prevention of the onset of pulmonary oxygen toxicity and/or reduction of decrements of pulmonary function due to pulmonary oxygen toxicity comprising administration of a prophylactically effective amount of an anticholinergic, optionally together with a pharmaceutically acceptable excipient.
    Type: Application
    Filed: March 26, 2019
    Publication date: September 26, 2019
    Inventors: Aaron A. Hall, William A. Cronin, Richard T. Mahon, William R. Johnson
  • Volatile organic compounds as diagnostic breath markers for pulmonary oxygen toxicity
    Patent number: 10261071
    Abstract: A set of volatile organic compounds is provided, comprising Benzene, 2,3,4-trimethyl-Pentane, 1,4-dimethyl-, trans-Cyclohexane, 2,2,4-trimethyl-Hexane, 1,7,7-trimethyl-Tricyclo[2.2.1.0(2,6)]heptane, and 4-ethyl-3-Octene for breath analysis. Methods of identifying these VOCs and use thereof in diagnosing, monitoring the onset of pulmonary toxicity are also disclosed.
    Type: Grant
    Filed: July 9, 2017
    Date of Patent: April 16, 2019
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Richard T. Mahon, Aaron A Hall, William A Cronin
  • VOLATILE ORGANIC COMPOUNDS AS DIAGNOSTIC BREATH MARKERS FOR PULMONARY OXYGEN TOXICITY
    Publication number: 20180180590
    Abstract: A set of volatile organic compounds is provided, comprising Benzene, 2,3,4-trimethyl-Pentane, 1,4-dimethyl-, trans-Cyclohexane, 2,2,4-trimethyl-Hexane, 1,7,7-trimethyl-Tricyclo[2.2.1.0(2,6)]heptane, and 4-ethyl-3-Octene for breath analysis. Methods of identifying these VOCs and use thereof in diagnosing, monitoring the onset of pulmonary toxicity are also disclosed.
    Type: Application
    Filed: July 9, 2017
    Publication date: June 28, 2018
    Applicant: The United States of America as represented by the secretary of the Navy
    Inventors: Richard T. Mahon, Aaron A. Hall, William A. Cronin